drugset / Trial / NCT02941016
Vascular Inflammation and Cholesterol Lowering Therapy
NaSingle-groupOpen-labelOther
Summary
This study aim to detect change in vascular inflammation following intense lipid lowering therapy
Timeline
- Start
- 2016-10
- Primary completion
- 2020-10
- Completion
- 2020-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alirocumab | Monoclonal antibody | — | — |
| Subject | Evolocumab | Monoclonal antibody | — | — |